Investigating the solubilization effect of oxcarbazepine by forming cocrystals
Author:
Affiliation:
1. College of Chemical Engineering
2. Beijing University of Chemical Technology
3. Beijing 100029
4. People's Republic of China
Abstract
Oxcarbazepine (OXCBZ) is a poorly soluble drug that can't form a salt. The apparent solubilities of the OXCBZ–OA and OXCBZ–2,5-DHBA cocrystals increased approximately 2.6 and 4.7 times of that of OXCBZ.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Beijing Municipality
Publisher
Royal Society of Chemistry (RSC)
Subject
Condensed Matter Physics,General Materials Science,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2019/CE/C9CE00651F
Reference33 articles.
1. Pharmaceutical cocrystals: along the path to improved medicines
2. Perphenazine–fumaric acid salts with improved solubility: preparation, physico-chemical characterization and in vitro dissolution
3. Polymeric prodrug of bufalin for increasing solubility and stability: Synthesis and anticancer study in vitro and in vivo
4. Improvement in solubility of poor water-soluble drugs by solid dispersion
5. Rational Analysis of Melting Point Behavior of Co-Crystals of 4-Nitrophenol with Some Aza-Compounds
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Environmentally Friendly High-Energy Oxidizers for Solid Rocket Propellants;Space Technology Library;2024
2. The enhanced pH-dependent solubility behavior of three novel lamotrigine-acid salts;Journal of Molecular Liquids;2023-07
3. New Chrysin-based co-crystals: Synthesis, characterization and dissolution studies;Journal of Molecular Structure;2023-01
4. Recent Advances on the Biological Study of Pharmaceutical Cocrystals;AAPS PharmSciTech;2022-11-17
5. Synthesis and dissolution behaviour of nateglinide‐nicotinamide cocrystals by simple slurry crystallization;The Canadian Journal of Chemical Engineering;2022-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3